Skip to main content
SpringerLink
Log in

Nuclear Cardiology in the Management of Patients with Heart Failure

  • Cardiac Nuclear Imaging (A Cuocolo, Section Editor)
  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

An Erratum to this article was published on 18 February 2016

Abstract

Heart failure is increasing worldwide, resulting in considerable disability, mortality, and high healthcare costs. Gated-SPECT or PET imaging is the most prominent imaging modality useful both for diagnosis and prognosis, capable of providing information about ventricular function, presence of intraventricular synchronism, and myocardial perfusion in the same test. In addition, PET can also offer quantification of coronary blood flow and metabolism. On the other hand, 123I- metaiodobenzylguanidine (MIBG) scintigraphy is the only imaging technique which provides information regarding the adrenergic function of the heart. This review provides an overview of the literature published over the past year relevant to this topic, presented in three parts: myocardial perfusion imaging, intraventricular synchronism assessment, and cardiac sympathetic innervation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Najafi F, Jamrozik K, Dobson AJ. Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure. Eur J Heart Fail. 2009;11:472–9.

    Article  PubMed  Google Scholar 

  2. Djousse L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA. 2009;302:394–400.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A. Worldwide risk factors for heart failure: a systematic review and pooled analysis. Int J Cardiol. 2013;168:1186–94.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.

    Article  PubMed  Google Scholar 

  5. Mc Murray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–47.

    Article  Google Scholar 

  6. International Atomic Energy Agency (IAEA). Nuclear Cardiology: guidance and recommendations for implementation in developing countries. IAEA Human Health Series No. 23 STI/PUB/1566. Vienna, Austria: IAEA; 2012.

  7. Peix A, Mesquita CT, Paez D, Pereira CC, Felix R, Gutierrez C, et al. Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA). Nucl Med Commun. 2014;35:818–23. This IAEA guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease.

    PubMed Central  CAS  PubMed  Google Scholar 

  8. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–8. Meta-analysis including 3 088 patients that demonstrated that patients with myocardial viability had a better outcome when revascularized than those without.

    Article  PubMed  Google Scholar 

  9. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Bax JJ, Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol. 2015;22:229–45. Careful and comprehensive analysis of myocardial viability as part of the complete assessment of ischemic heart failure to provide optimal and personalized therapy to these patients.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002–12.

    Article  PubMed  Google Scholar 

  12. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.

    Article  PubMed  Google Scholar 

  13. Mut F, Giubbini R, Vitola J, Lusa L, Sobic-Saranovic D, Peix A, et al. Detection of post-exercise stunning by early gated SPECT myocardial perfusion imaging: results from the IAEA multi-center study. J Nucl Cardiol. 2014;21:1168–76.

    Article  PubMed  Google Scholar 

  14. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report–2012. J Heart Lung Transplant. 2012;31:1052–64.

    Article  PubMed  Google Scholar 

  15. Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al. International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–56.

    Article  PubMed  Google Scholar 

  16. Pollack A, Nazif T, Mancini D, Weisz G. Detection and imaging of cardiac allograft vasculopathy. J Am Coll Cardiol Cardiovasc Imaging. 2013;6:613–23.

    Article  Google Scholar 

  17. Mc Ardle BA, Davies RA, Chen L, Small GR, Ruddy TD, Dwivedi G, et al. Prognostic value of Rubidium-82 positron emission tomography in patients after heart transplant. Circ Cardiovasc Imaging. 2014;7:930–7.

    Article  Google Scholar 

  18. Wollenweber T, Bengel FM. Cardiac molecular imaging. Semin Nucl Med. 2014;44:386–97.

    Article  PubMed  Google Scholar 

  19. Mc Ardle BA, Leung E, Ohira H, Cocker MS, de Kemp RA, Da Silva J, et al. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20:297–306.

    Article  CAS  PubMed  Google Scholar 

  20. Ayoub C, Pena E, Ohira H, Dick A, Leung E, Nery PB, et al. Advanced imaging of cardiac sarcoidosis. Curr Cardiol Rep. 2015;17(4):17. doi:10.1007/s11886-015-0572-1.

    Article  PubMed  Google Scholar 

  21. Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53:241–8.

    Article  CAS  PubMed  Google Scholar 

  22. Jivraj N, Phinikaridou A, Shah AM, Botnar RM. Molecular imaging of myocardial infarction. Basic Res Cardiol. 2014;109(1):397. doi:10.1007/s00395-013-0397-2. Review of novel non-invasive imaging methods, using targeted imaging agents, which allow imaging of the molecular processes underlying the post-myocardial infarction immune cell response, and subsequent remodeling.

    Article  PubMed  Google Scholar 

  23. Majmudar MD, Murthy VL, Shah RV, Kolli S, Mousavi N, Foster CR. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015;16:900–9.

    Article  PubMed  Google Scholar 

  24. Prior JO, Farhad H, Muller O. Multimodality imaging in ischemic cardiomyopathy. Curr Cardiovasc Imaging Rep. 2014;7:9285. Up-to-date comprehensive overview of cardiac multimodality imaging already in clinical use, as well as a combination of techniques with promising or developing applications.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Flotats A, Knuuti J, Gutberlet M, Marcassa C, Bengel FM, Kaufmann PA, et al. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging. 2011;38:201–12.

    Article  PubMed  Google Scholar 

  26. Lin X, Xu H, Zhao X, Chen J. Sites of latest mechanical activation as assessed by SPECT myocardial perfusion imaging in ischemic and dilated cardiomyopathy patients with LBBB. Eur J Nucl Med Mol Imaging. 2014;41:1232–9.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Bose A, Kandala J, Upadhyay GA, Riedl L, Ahmado I, Padmanabhan R, et al. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014;25:507–13.

    Article  PubMed  Google Scholar 

  28. Botvinick EH, Badhwar N, O’Connell JW. Cardiac resynchronization therapy: the role of equilibrium radionuclide angiography. Medicamundi. 2008;52:51–8.

    Google Scholar 

  29. Toussaint JF, Peix A, Lavergne T, Ponce F, Froissart M, Alonso C, et al. Reproducibility of the ventricular synchronization parameters assessed by multiharmonic phase analysis of radionuclide angiography in the normal heart. Int J Cardiovasc Imaging. 2002;18:187–94.

    Article  CAS  PubMed  Google Scholar 

  30. Lalonde M, Birnie D, Ruddy TD, de Kemp RA, Beanlands RS, Wassenaar R, et al. SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response. Int J Cardiovasc Imaging. 2014;30:559–69.

    Article  PubMed  Google Scholar 

  31. Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol. 2005;12:687–95.

    Article  PubMed  Google Scholar 

  32. Zafrir N, Nevzorov R, Bental T, Strasberg B, Gutstein A, Mats I, et al. Prognostic value of left ventricular dyssynchrony by myocardial perfusion-gated SPECT in patients with normal and abnormal left ventricular functions. J Nucl Cardiol. 2014;21:532–40.

    Article  PubMed  Google Scholar 

  33. Hess PL, Shaw LK, Vemulapalli S, Pagnanelli R, O’Connor CM, Borges-Neto S. An alternative method to examine the predictive value of mechanical dyssynchrony. J Nucl Cardiol. 2015;22:686–9.

    Article  PubMed  Google Scholar 

  34. Borges-Neto S, Samad Z. In search of the perfect indicators of left ventricular mechanical dyssynchrony. J Nucl Cardiol. 2015;22:1259–61.

    Article  PubMed  Google Scholar 

  35. Romero-Farina G, Aguadé-Bruix S, Candell-Riera J, Pizzi MN, García-Dorado D. Cut-off values of myocardial perfusion gated-SPECT phase analysis parameters of normal subjects, and conduction and mechanical cardiac diseases. J Nucl Cardiol. 2015;22:1247–58.

    Article  PubMed  Google Scholar 

  36. Samad Z, Atchley A, Trimble M, Sun JL, Shaw LK, Pagnanelli R, et al. Prevalence and predictors of mechanical dyssynchrony as defined by phase analysis in patients with left ventricular dysfunction undergoing gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2011;18:24–30.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Aljaroudi W, Koneru J, Heo J, Iskandrian AE. Impact of ischemia on left ventricular dyssynchrony by phase analysis of gated single photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol. 2011;18:36–42.

    Article  PubMed  Google Scholar 

  38. Chen CC, Shen TY, Chang MC, Hung GU, Chen WC, Kao CH, et al. Stress-induced myocardial ischemia is associated with early post-stress left ventricular mechanical dyssynchrony as assessed by phase analysis of 201Tl gated SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2012;39:1904–9.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Mukherjee A, Patel CD, Naik N, Sharma G, Roy A. Quantitative assessment of cardiac mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy in patients with nonischaemic dilated cardiomyopathy using gated myocardial perfusion SPECT. Nucl Med Commun. 2015;36:494–501.

    PubMed  Google Scholar 

  40. Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADITCRT) Trial. Circulation. 2011;123:1159–66.

    Article  PubMed  Google Scholar 

  41. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O’Halloran D, Elsik M, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59:1509–18.

    Article  PubMed  Google Scholar 

  42. Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369:1395–405.

    Article  CAS  PubMed  Google Scholar 

  43. Zhou W, Hou X, Piccinelli M, Tang X, Tang L, Cao K, et al. 3D Fusion of LV venous anatomy on fluoroscopy venograms with epicardial surface on SPECT myocardial perfusion images for guiding CRT LV lead placement. J Am Coll Cardiol Img. 2014;7:1239–48.

    Article  Google Scholar 

  44. Atchley AE, Iskandrian AE, Bensimhon D, Ellis SJ, Kitzman DW, Shaw LK, et al. HF-ACTION Trial Nuclear Ancillary Study Investigators. Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial. Am Heart J. 2011;161:1038–45.

    Article  PubMed Central  PubMed  Google Scholar 

  45. AlJaroudi W, Alraies C, Hachamovitch R, Jaber WA, Brunken R, Cerqueira MD, et al. Association of left ventricular mechanical dyssynchrony with survival benefit from revascularization: a study of gated positron emission tomography in patients with ischemic LV dysfunction and narrow QRS. Eur J Nucl Med Mol Imaging. 2012;39:1581–91.

    Article  PubMed  Google Scholar 

  46. Peix A, Karell J, Rodriguez L, Cabrera LO, Padron K, Carrillo R, et al. Gated SPECT myocardial perfusion imaging, intraventricular synchronism, and cardiac events in heart failure. Clin Nucl Med. 2014;39:498–504.

    Article  PubMed  Google Scholar 

  47. Haugaa KH, Smedsrud MK, Steen T, Kongsgaard E, Loennechen JP, Skjaerpe T, et al. Mechanical dispersion assessed by myocardial strain in patients after myocardial infarcti.on for risk prediction of ventricular arrhythmia. J Am Coll Cardiol Img. 2010;3:247–56.

    Article  Google Scholar 

  48. Murrow J, Esteves F, Galt J, Chen J, Garcia E, Lin J, et al. Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. J Nucl Cardiol. 2011;18:912–9.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Hage FG. Left ventricular mechanical dyssynchrony by phase analysis as a prognostic indicator in heart failure. J Nucl Cardiol. 2014;21:67–70.

    Article  PubMed  Google Scholar 

  50. Goldberg AS, Alraies MC, Cerqueira MD, Jaber WA, Aljaroudi WA. Prognostic value of left ventricular mechanical dyssynchrony by phase analysis in patients with non-ischemic cardiomyopathy with ejection fraction 35-50% and QRS < 150 ms. J Nucl Cardiol. 2014;21:57–66.

    Article  PubMed  Google Scholar 

  51. Peix A, Macides A, Rodriguez L, Cabrera LO, Padron K, Heres F, et al. Stress–rest myocardial perfusion scintigraphy and adverse cardiac events in heart failure patients. MEDICC Rev. 2015;17:33–8.

    PubMed  Google Scholar 

  52. Hage FG, Aggarwal H, Patel K, Chen J, Jacobson AF, Heo J, et al. The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure. J Nucl Cardiol. 2014;21:78–85.

    Article  PubMed  Google Scholar 

  53. Chen X, Werner RA, Javadi MS, Maya Y, Decker M, Lapa C, et al. Radionuclide imaging of neurohormonal system of the heart. Theranostics. 2015;5:545–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Fallavollita JA, Heavey BM, Luisi Jr AJ, Michalek SM, Baldwa S, Mashtare Jr TL, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63:141–9.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 metaiodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212–21. The ADMIRE-HF demonstrated the capacity of quantitation of sympathetic innervation of the myocardium, measured by the H/M on 123 I-MIBG scintigraphy, for predicting prognosis for significant cardiac events in subjects with HF and significant left ventricular dysfunction, independently of independent of other commonly measured parameters such as LVEF and BNP.

  56. Eckelman WC, Dilsizian V. Chemistry and biology of radiotracers that target changes in sympathetic and parasympathetic nervous systems in heart disease. J Nucl Med. 2015;56:7S–10.

    Article  CAS  PubMed  Google Scholar 

  57. Jacobson AF, Narula J. Introduction to cardiac neuronal imaging: a clinical perspective. J Nucl Med. 2015;56:3S–6.

    Article  CAS  PubMed  Google Scholar 

  58. Nakajima K, Nakata T. Cardiac 123I-MIBG imaging for clinical decision making: 22-year experience in Japan. J Nucl Med. 2015;56:11S–9.

    Article  CAS  PubMed  Google Scholar 

  59. Dimitriu-Leen AC, Scholte AJ, Jacobson AF. 123I-MIBG SPECT for evaluation of patients with heart failure. J Nucl Med. 2015;56:25S–30.

    Article  PubMed  Google Scholar 

  60. Travin MI. Cardiac radionuclide imaging to assess patients with heart failure. Semin Nucl Med. 2014;44:294–313.

    Article  PubMed  Google Scholar 

  61. Boogers MJ, Borleffs CJW, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769–77.

    Article  PubMed  Google Scholar 

  62. Rijnierse MT, Allaart CP, de Haan S, Harms HJ, Huisman MC, Wu L, et al. Sympathetic denervation is associated with microvascular dysfunction in non-infarcted myocardium in patients with cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2015;16:788–98.

    Article  PubMed  Google Scholar 

  63. Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman TM. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy. J Nucl Cardiol. 2014;21:756–62.

    Article  PubMed  Google Scholar 

  64. Wessler BS, Udelson JE. Neuronal dysfunction and medical therapy in heart failure: can an imaging biomarker help to “personalize” therapy? J Nucl Med. 2015;56:20S–4.

    Article  CAS  PubMed  Google Scholar 

  65. Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera collimator variations. J Nucl Cardiol. 2014;21:970–8.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A, et al. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging. 2014;15:996–1003.

    Article  PubMed  Google Scholar 

  67. Leosco D, Parisi V, Pellegrino T, Pagano G, Femminella GD, Bevilacqua A, et al. Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac 123I-MIBG study. Eur J Nucl Med Mol Imaging. 2015;42:1601–11.

    Article  PubMed  Google Scholar 

  68. JCS Joint Working Group. Guidelines for Clinical Use of Cardiac Nuclear Medicine (JCS 2010): digest version. Circ J. 2012;76:761–7.

    Article  Google Scholar 

  69. Abdulghani M, Duell J, Smith M, Chen W, Bentzen SM, Asoglu R, et al. Global and regional myocardial innervation before and after ablation of drug-refractory ventricular tachycardia assessed with 123I-MIBG. J Nucl Med. 2015;56:52S–8.

    Article  CAS  PubMed  Google Scholar 

  70. Borgquist R, Singh JP. An electrophysiologist perspective on risk stratification in heart failure: can better understanding of the condition of the cardiac sympathetic nervous system help? J Nucl Med. 2015;56:59S–64.

    Article  PubMed  Google Scholar 

  71. Zhou Y, Zhou W, Folks RD, Manatunga DN, Jacobson AF, Bax JJ, et al. I-123 MIBG and Tc-99m myocardial SPECT imaging to predict inducibility of ventricular arrhythmia on electrophysiology testing: a retrospective analysis. J Nucl Cardiol. 2014;21:913–20.

    Article  PubMed  Google Scholar 

  72. Klein T, Abdulghani M, Smith M, Huang R, Asoglu R, Remo BF, et al. Three-dimensional 123I-meta-iodobenzylguanidine cardiac innervation maps to assess substrate and successful ablation sites for ventricular tachycardia: a feasibility study for a novel paradigm of innervation imaging. Circ Arrhythm Electrophysiol. 2015;8:583–91.

    Article  PubMed  Google Scholar 

  73. Verberne H, Henzlova M, Jain D. 123I-MIBG and 99mTc-tetrofosmin SPECT for prediction of arrhythmic risk in ischemic heart failure patients [abstract]. J Nucl Med. 2014;55 suppl 1:182.

    Google Scholar 

  74. Clements IP, Garcia EV, Folks RD, Butler J, Jacobson AF. Differences in myocardial sympathetic innervation and perfusion in patients with ischemic versus non-ischemic heart failure. J Card Fail. 2014;20(suppl):S17.

    Article  Google Scholar 

  75. Clements IP, Garcia EV, Chen J, Folks RD, Butler J, Jacobson AF. Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT. J Nucl Cardiol. 2015

  76. Gimelli A, Liga R, Giorgetti A, Genovesi D, Marzullo P. Assessment of myocardial adrenergic innervation with a solid-state dedicated cardiac cadmium zinc telluride camera: first clinical experience. Eur Heart J Cardiovasc Imaging. 2014;15:575–85.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Adrienne Hunter, Ph.D., for her patience and dedication in reviewing the manuscript.

Author information

Authors and Affiliations

  1. Nuclear Medicine Department, Institute of Cardiology, 17 No. 702, Vedado, CP, 10 400, La Habana, Cuba

    Amalia Peix, Lázaro O. Cabrera & Kenia Padrón

Authors
  1. Amalia Peix
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lázaro O. Cabrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenia Padrón
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amalia Peix.

Ethics declarations

Conflict of Interest

Amalia Peix, Lázaro O. Cabrera, and Kenia Padrón declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the coauthors. All studies by Amalia Peix involving animal and/or human subjects were performed after approval by the appropriate institutional review boards. When required, written informed consent was obtained from all participants.

Additional information

This article is part of the Topical Collection on Cardiac Nuclear Imaging

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peix, A., Cabrera, L.O. & Padrón, K. Nuclear Cardiology in the Management of Patients with Heart Failure. Curr Cardiovasc Imaging Rep 9, 1 (2016). https://doi.org/10.1007/s12410-015-9363-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12410-015-9363-8

Keywords

Search

Navigation